1. Home
  2. SINT vs IMNN Comparison

SINT vs IMNN Comparison

Compare SINT & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.32

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$2.83

Market Cap

11.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
IMNN
Founded
1996
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
11.0M
IPO Year
2007
2000

Fundamental Metrics

Financial Performance
Metric
SINT
IMNN
Price
$2.32
$2.83
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$16.00
$182.61
AVG Volume (30 Days)
26.5K
51.7K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
25.00
EPS
N/A
N/A
Revenue
$1,018,000.00
N/A
Revenue This Year
$80.35
N/A
Revenue Next Year
$270.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$0.37
52 Week High
$6.78
$9.32

Technical Indicators

Market Signals
Indicator
SINT
IMNN
Relative Strength Index (RSI) 25.32 37.75
Support Level N/A $0.48
Resistance Level $2.96 $3.16
Average True Range (ATR) 0.17 0.23
MACD -0.03 -0.02
Stochastic Oscillator 0.00 40.00

Price Performance

Historical Comparison
SINT
IMNN

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: